Results 51 to 60 of about 82,991 (273)

Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort studyResearch in context

EClinicalMedicine, 2023
Summary: Background: Renin-angiotensin-system inhibitors (RASi), that include angiotensin converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) reduce proteinuria, delay chronic kidney disease (CKD) progression, protect against ...
Aimin Yang, Mai Shi, Eric S.H. Lau, Hongjiang Wu, Xinge Zhang, Baoqi Fan, Alice P.S. Kong, Andrea O.Y. Luk, Ronald C.W. Ma, Juliana C.N. Chan, Elaine Chow   +10 more
doaj   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Risk factors for angiotensin converting enzyme inhibitor angioedema in a South African population

Frontiers in Allergy
IntroductionAngiotensin converting enzyme inhibitors (ACEI) have proven mortality and morbidity benefit in hypertension, ischemic heart disease, heart failure, and renal disease and are among the most prescribed medications globally.
Cascia Day, Cascia Day, Lovemore Mapahla, Lovemore Mapahla, Melissa Ribeiro, Mimi Deetlefs, Cathryn McDougall, Adelein Engelbrecht, Erika Jones, Sarah Pedretti, Jonny Peter, Jonny Peter   +11 more
doaj   +1 more source

Impact of a “Chart Closure” Hard Stop Alert on Prescribing for Elevated Blood Pressures Among Patients With Diabetes: Quasi-Experimental Study

JMIR Medical Informatics, 2020
BackgroundUniversity of California at Los Angeles Health implemented a Best Practice Advisory (BPA) alert for the initiation of an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-receptor blocker (ARB) for individuals with diabetes. The BPA
Ramirez, Magaly, Chen, Kimberly, Follett, Robert W, Mangione, Carol M, Moreno, Gerardo, Bell, Douglas S   +5 more
doaj   +1 more source

Life‐threatening bronchospasm induced by an angiotensin‐converting enzyme inhibitor in a chronically ventilated patient: Diagnostic pitfalls and literature review

Respirology Case Reports, 2023
Cough‐ and asthma‐like symptoms are common adverse reactions to angiotensin‐converting enzyme inhibitors (ACEi). However, attributing these symptoms to the use of ACEi might be masked by clinical confounders.
Esther‐Lee Marcus, Amir Hush, Hisham Atrash, Roaia Shibli, Samuel N. Heyman   +4 more
doaj   +1 more source

Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis [PDF]

, 2014
Background: Some studies but not others suggest angiotensin converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) use prior to major surgery associates with a higher risk of postoperative acute kidney injury (AKI) and death.
Brunelli, Steven M, Coca, Steven G, Devereaux, Philip J, Garg, Amit X, Jain, Arsh K, James, Matthew T, Luo, Jin, Molnar, Amber O, Mrkobrada, Marko, Pannu, Neesh, Parikh, Chirag R, Paterson, Michael, Shah, Mitesh, Shariff, Salimah, Wald, Ron, Walsh, Michael, Whitlock, Richard, Wijeysundera, Duminda N   +17 more
core   +2 more sources

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki, Tetsu Watanabe, Mari Shimizu, Shingo Tachibana, Junya Sato, Yuta Kobayashi, Harutoshi Tamura, Shigehiko Kato, Satoshi Nishiyama, Hiroki Takahashi, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

Angiotensin-converting enzyme inhibitor-induced angioedema: Proposal for a diagnostic score

World Allergy Organization Journal
Objective: Angiotensin-converting enzyme inhibitor (ACEI)-induced angioedema (AE-ACEI) may be life-threatening, and the treatment should therefore be discontinued.
Alexis Bocquet, MD, Nicolas Marmion, MD, Isabelle Boccon-Gibod, MD, Laurence Bouillet, MD, PhD   +3 more
doaj   +1 more source

Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease

Chinese Medical Journal, 2016
Background: Renin-angiotensin system inhibitor and calcium channel blocker (CCB) are widely used in controlling blood pressure (BP) in patients with chronic kidney disease (CKD).
Rong-Shuang Huang, Yi-Ming Cheng, Xiao-Xi Zeng, Sehee Kim, Ping Fu   +4 more
doaj   +1 more source

Impact of renin–angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study

Journal of International Medical Research, 2020
Objective Association of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) use with coronavirus disease 2019 (COVID-19) remains controversial.
Yanjun Zhong, Lishu Zhao, Guobao Wu, Chunhong Hu, Chenfang Wu, Min Xu, Haiyun Dong, Quan Zhang, Guyi Wang, Bo Yu, Jianlei Lv, Chao Wu, Siye Zhang, Chenghui Cao, Long Shu, Yue Pan, Xianling Liu, Fang Wu   +17 more
doaj   +1 more source